Marijuana-Based Epilepsy Drug Could Hit The U.S. Market By Mid-2018 January 25, 2018 AggregatedNews Policy & Legal 0 Comments A new class of epilepsy medications based on an ingredient derived from marijuana could be available as soon as the second half of 2018 in the United States, pending Food and Drug Administration approval. Officials from GW Pharmaceuticals, the company that developed the… Read More→